Results
eNauka >
Results >
Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study
| Title: | Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study | Authors  : | Ellebaek, Eva; ...; Dujovic, Branko; ...; (broj, koautora 49) | Issue Date: | 2026 | Publication: | EJC SKIN CANCER | ISSN: | 2772-6118  Search Idenfier |
Type: | Article | Collation: | vol. 4 str. 100773-100773 | DOI: | 10.1016/j.ejcskn.2025.100773 | WoS-ID: | 001791987500003 | Scopus-ID: | 2-s2.0-105027470223 | URI: | https://enauka.gov.rs/handle/123456789/1047481 | Project: | Novartis AG, Basel, Switzerland | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.